Mutational profiling of the variability of individual amino acid positions in the hepatitis B virus matrix domain.
Virology 458-459, 183-189 (2014)
The hepatitis B virus (HBV) is formed by budding. A stretch of 22 amino acids (aa) (matrix domain, MD, R103 - S124) in the large envelope protein L is crucial for virion formation and probably establishes contact to the nucleocapsid. Here, we assess the impact of sequence variations at numerous individual aa positions within the MD on virion formation. We generated panels of L mutants covering all 19 possible aa for 11 positions and tested the capacity of these mutants to rescue virus production by an L-defective HBV genome. At four positions (L112, R113, P117, W122), any replacement of the wild type (WT) aa reduced virus assembly to undetectable levels. Virus production was strongly diminished by substitutions at five other positions (R103, T106, S115, H116, A119). Only two tested positions (D114, Q118) tolerated several substitutions. The restricted positions may represent promising targets for the development of novel antiviral strategies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Envelopment ; Hepatitis B Virus ; Large Surface Protein ; Matrix Domain; Large Envelope Protein; Pre-s Domain; Transmembrane Topology; Virion Formation; Surface; Morphogenesis; Capsids; Replication; Sequence
Keywords plus
Language
english
Publication Year
2014
Prepublished in Year
HGF-reported in Year
2014
ISSN (print) / ISBN
0042-6822
e-ISSN
0042-6822
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 458-459,
Issue: 1,
Pages: 183-189
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
San Diego
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-005
Grants
Copyright
Erfassungsdatum
2014-06-16